Article
French biotech stock soars 30% after new data on experimental medicine
Neutral
0.0
−100 Bearish
0
+100 Bullish
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Source
CNBC Top Stories
Published
Jun 30, 2026 · 8:43 am
Article ID
gi6g5j9
Original URL
Open source
Sentiment Signal
Neutral
0.0
−100Neutral+100
More Like This